LONN.SW
EBSLONZA N
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
Contexte du mouvement
Pas de cause dominante- Aucun driver net (marché, secteur, résultats, technique) ne ressort.
Drivers prévisibles à venir
- Échéances d'options · 16/10/2026 (J+6)
- Rebalancement d'indices · 18/12/2026 (J+69)
Contexte quantitatif — information à titre indicatif, pas un conseil en investissement.
Dividendes & société
LONN.SW · CHF
Sources : yahoo. Informations à titre indicatif, pas un conseil.
Consensus analystes
Sources : yahoo. Consensus d'analystes sell-side — information à titre indicatif, pas un conseil en investissement.
Contenu réservé aux membres
Créez un compte gratuit pour accéder à l'intelligence de marché de LONN.SW : corrélations, insights IA et actualités.
Accès libre sur les actions et ETF les plus suivis
Actualités liées
Budget de l'Union européenne : l'Irlande propose une réduction des dépenses de 8 % - Les Echos
Budget de l'Union européenne : l'Irlande propose une réduction des dépenses de 8 % Les Echos
Actualités du 09 octobre 2026
Actualités du 09 octobre 2026 Boursorama
Patriot Mobile, opérateur de téléphonie mobile chrétien-conservateur, dépose une demande d'introduction en bou
Patriot Mobile, opérateur de téléphonie mobile chrétien-conservateur, dépose une demande d'introduction en bou Boursorama
Base Electron dépose en toute confidentialité une demande d'introduction en Bourse aux États-Unis
Base Electron dépose en toute confidentialité une demande d'introduction en Bourse aux États-Unis Boursorama
BOURSE DU CANADA-Le TSX enregistre sa plus forte hausse en cinq semaines alors que les anticipations de hausse
BOURSE DU CANADA-Le TSX enregistre sa plus forte hausse en cinq semaines alors que les anticipations de hausse Boursorama
Wall Street termine la semaine en hausse - Investir Les Echos
Wall Street termine la semaine en hausse Investir Les Echos
vVardis prépare son entrée à Wall Street après avoir triplé ses revenus
vVardis prépare son entrée à Wall Street après avoir triplé ses revenus Boursorama
Gene Transfer Technologies Market Size, Share & Trends Analysis to 2036 Featuring Profiles of Thermo Fisher Scientific, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Aldevron and More
Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.The global Gene Transfer Technologies Market is projected to witness robust growth during the forecast period from 2026 to 2036, driven by the rapid expansion of gene and cell therapies, increasing investments in genomic medicine, and continuous advancements in vector engine
Europe Automated and Closed Cell Therapy Processing Systems Market Report (2026-2033) Featuring Profiles of Thermo Fisher Scientific, Cytiva, Sartorius, Miltenyi Biotec B.V. & Co., Lonza Group
Europe’s cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturingDublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Europe Automated and Closed Cell Therapy Processing Systems Market Size, Share & Industry Analysis Report by Type, Scale, Workflow, Country Outlook and Forecast, 2026-2033" has been added to ResearchAndMarkets.com's offering. The Europe automated and closed cell therapy pr
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient formulations provide the essential environment for growing and maintaining cells used in biopharmaceutical manufacturing, vaccine production, regenerative medicine, and advanced biomedical research.
[Latest] Global Bioprocess Digital Twin Market Size/Share Worth USD 6.47 Billion by 2035 at a 19.6% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Bioprocess Digital Twin Market size & share revenue was valued at approximately USD 0.89 Billion in 2025 and is expected to reach USD 1.08 Billion in 2026 and is expected to reach around USD 6.47 Billion by 2035, at a CAGR of 19.6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Siemens AG (SIMATIC Biopr
[Latest] Global Stem Cell Culture Media Market Size/Share Worth USD 2714 Million by 2035 at a 13.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Stem Cell Culture Media Market size & share revenue was valued at approximately USD 765 Million in 2025 and is expected to reach USD 868 Million in 2026 and is expected to reach around USD 2714 Million by 2035, at a CAGR of 13.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are PAN Biotech GmbH, Sartorius
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media Market is projected to grow from USD 3.7 billion in 2026 to USD 7.1 billion by 2036, expanding at a CAGR of 6.6% during the forecast period. Market growth is being driven by rising biologics production, expanding cell and gene therapy pipelines, increasing adoption of serum-free formulations, and growing demand for reproducible, GMP-grade manufacturing inputs across regulated biopharmaceutical
[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Cell Culture Media Bags Market size & share revenue was valued at approximately USD 1.30 Billion in 2025 and is expected to reach USD 1.37 Billion in 2026 and is expected to reach around USD 2.28 Billion by 2035, at a CAGR of 5.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are GE Healthcare, Thermo Fish
Is Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings?
Wondering whether Lonza Group at about CHF 508 per share still makes sense for your portfolio, or if better value is available elsewhere? The stock has been fairly volatile recently, with a 4.8% decline over the last week, an 8.7% gain over the last month, and returns of 5.1% lower year to date and 8.9% lower over the last year. Recent coverage has focused on how Lonza Group fits into the wider life sciences sector and what that might mean for investor sentiment. This news context helps...
Les données sont fournies à titre informatif. PunkMarket n'est pas un conseiller financier.